Antiviral Activities of Streptomyces KSF 103 Methanolic Extracts against Dengue Virus Type-2

Dengue has long been a serious health burden to the global community, especially for those living in the tropics. Despite the availability of vaccines, effective treatment for the infection is still needed and currently remains absent. In the present study, the antiviral properties of the Streptomyc...

Full description

Saved in:
Bibliographic Details
Published in:Viruses 2023-08, Vol.15 (8), p.1773
Main Authors: Zulkifli, Nurfatihah, Khairat, Jasmine-Elanie, Azman, Adzzie-Shazleen, Baharudin, Nur-Faralyza Mohd, Malek, Nurul-Adila, Zainal Abidin, Syafiq-Asnawi, AbuBakar, Sazaly, Hassandarvish, Pouya
Format: Article
Language:English
Subjects:
Adsorption
Analgesics
Antiviral activity
antivirals
arbovirus
Cell culture
Clinical trials
Cytotoxicity
Dengue fever
dengue virus
Disease
Enzymes
Genomes
Glycerol
Infections
Mosquitoes
Polymerase chain reaction
Proteins
Regulatory approval
Replication
Streptomyces
Vaccines
Viruses
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Dengue has long been a serious health burden to the global community, especially for those living in the tropics. Despite the availability of vaccines, effective treatment for the infection is still needed and currently remains absent. In the present study, the antiviral properties of the Streptomyces sp. KSF 103 methanolic extract (Streptomyces KSF 103 ME), which consists of a number of potential antiviral compounds, were investigated against dengue virus serotype 2 (DENV-2). The effects of this extract against DENV-2 replication were determined using the quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Findings from the study suggested that the Streptomyces KSF 103 ME showed maximum inhibitory properties toward the virus during the virus entry stage at concentrations of more than 12.5 µg/mL. Minimal antiviral activities were observed at other virus replication stages; adsorption (42% reduction at 50 µg/mL), post-adsorption (67.6% reduction at 50 µg/mL), prophylactic treatment (68.4% and 87.7% reductions at 50 µg/mL and 25 µg/mL, respectively), and direct virucidal assay (48% and 56.8% reductions at 50 µg/mL and 25 µg/mL, respectively). The Streptomyces KSF 103 ME inhibited dengue virus replication with a 50% inhibitory concentration (IC50) value of 20.3 µg/mL and an International System of Units (SI) value of 38.9. The Streptomyces KSF 103 ME showed potent antiviral properties against dengue virus (DENV) during the entry stage. Further studies will be needed to deduce the antiviral mechanisms of the Streptomyces KSF 103 ME against DENV.
ISSN:1999-4915
1999-4915
DOI:10.3390/v15081773